CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIENCY - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	47,556,267
Beginning balance	$ (130,328)	$ (58,995)
Issuance of common stock upon conversion of series G convertible preferred stock	168
Issuance of common stock in connection with exchange of debt		15,000
Issuance of common stock in connection with private placement		12,000
Issuance of common stock for restricted stock units		0
Common stock withheld for taxes	$ (29)	(534)
Repurchase of common stock for Fexy put option		(379)
Issuance of common stock upon exercise of stock options (in shares)	7,205
Issuance of common stock upon exercise of stock options	$ (4)
Stock-based compensation	510	3,290
Net income (loss)	$ 124,858	$ (100,710)
Ending balance (in shares)	47,594,930	47,556,267
Ending balance	$ (4,825)	$ (130,328)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	47,556,267	23,836,706
Beginning balance	$ 475	$ 237
Issuance of common stock upon conversion of series G convertible preferred stock (in shares)	8,582
Issuance of common stock in connection with exchange of debt (in shares)		17,797,817
Issuance of common stock in connection with exchange of debt		$ 178
Issuance of common stock in connection with private placement (in shares)		5,555,555
Issuance of common stock in connection with private placement		$ 56
Issuance of common stock for restricted stock units (in shares)	34,056	971,863
Issuance of common stock for restricted stock units		$ 10
Common stock withheld for taxes (in shares)	(6,901)	(330,982)
Common stock withheld for taxes		$ (3)
Repurchase of common stock for Fexy put option (in shares)		(274,692)
Repurchase of common stock for Fexy put option		$ (3)
Issuance of common stock upon exercise of stock options (in shares)	2,926
Issuance of common stock upon exercise of stock options	$ 7
Ending balance (in shares)	47,594,930	47,556,267
Ending balance	$ 482	$ 475
Common To Be Issued
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	2,701	2,701
Beginning balance	$ 0	$ 0
Ending balance (in shares)	2,701	2,701
Ending balance	$ 0	$ 0
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	348,560	319,421
Issuance of common stock upon conversion of series G convertible preferred stock	168
Issuance of common stock in connection with exchange of debt		14,822
Issuance of common stock in connection with private placement		11,944
Issuance of common stock for restricted stock units		(10)
Common stock withheld for taxes	(29)	(531)
Repurchase of common stock for Fexy put option		(376)
Issuance of common stock upon exercise of stock options	(11)
Stock-based compensation	510	3,290
Ending balance	349,198	348,560
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(479,363)	(378,653)
Net income (loss)	124,858	(100,710)
Ending balance	$ (354,505)	$ (479,363)